1 |
Amniotic epithelial cells |
Amniotic Epithelial Cells |
- |
- |
- |
026 1件: 26 💬 |
2 |
Bortezomib |
Bortezomib |
1件: D03150 D03150 💬 |
PSMB5 1件: PSMB5 💬 |
Alzheimer disease 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
011 15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬 |
3 |
Ciclosporin |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
026 13件: 26, 46, 49, 50, 53, 55, 60, 61, 97, 222, 226, 228, 269 💬 |
4 |
Costicosteroids |
- |
- |
- |
- |
026 1件: 26 💬 |
5 |
Cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
011 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
6 |
Doxorubicin |
Doxorubicin |
1件: D03899 D03899 💬 |
TOP2A 2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
026 4件: 26, 28, 34, 331 💬 |
7 |
Doxorubicin hydrochloride |
Doxorubicin |
1件: D03899 D03899 💬 |
TOP2A 2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
026 3件: 26, 34, 331 💬 |
8 |
Etoposide |
Etoposide |
2件: D00125 D00125, D04107 D04107 💬 |
TOP2A 2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
011 11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬 |
9 |
Filgrastim |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 27件: 2 , 6 , 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
10 |
Hu mik-beta-1 |
- |
- |
- |
- |
026 1件: 26 💬 |
11 |
Human interferon beta |
Human interferon beta |
- |
- |
- |
013 2件: 13, 26 💬 |
12 |
Interferon alfa |
Interferon alfa |
1件: D03305 D03305 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
025 5件: 25, 26, 28, 56, 96 💬 |
13 |
Interferon beta |
Human interferon beta |
- |
- |
- |
013 5件: 13, 20, 26, 96, 97 💬 |
14 |
Interferon beta-1a |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 4件: 13, 26, 96, 97 💬 |
15 |
Kw-0761 |
- |
- |
- |
- |
026 1件: 26 💬 |
16 |
Kw-0761 0.3 mg/kg iv |
- |
- |
- |
- |
026 1件: 26 💬 |
17 |
Lamivudine |
Lamivudine |
1件: D00353 D00353 💬 |
- |
- |
026 6件: 26, 42, 46, 135, 265, 325 💬 |
18 |
Lenalidomide |
Lenalidomide |
1件: D04687 D04687 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
016 7件: 16, 26, 28, 34, 49, 284, 300 💬 |
19 |
Methylprednisolone |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
20 |
Mogamulizumab |
Mogamulizumab |
1件: D09761 D09761 💬 |
CCR4 1件: CCR4 💬 |
Chemokine signaling pathway 5件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Kaposi sarcoma-associated herpesvirus infection, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor |
026 1件: 26 💬 |
21 |
Nivolumab |
Nivolumab |
1件: D10316 D10316 💬 |
PDCD1 1件: PDCD1 💬 |
Cell adhesion molecules 3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway |
013 12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬 |
22 |
Nk cells |
Natural Killer Cell |
- |
- |
- |
026 1件: 26 💬 |
23 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 21件: 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
24 |
Other: pharmacogenomic study |
- |
- |
- |
- |
026 1件: 26 💬 |
25 |
Pentosan polysulfate |
Pentosan polysulfate |
1件: D05428 D05428 💬 |
- |
- |
019 3件: 19, 26, 226 💬 |
26 |
Pentoxifylline |
Pentoxifylline |
1件: D00501 D00501 💬 |
- |
- |
026 10件: 26, 56, 84, 93, 96, 113, 220, 222, 296, 298 💬 |
27 |
Prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
28 |
Prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
29 |
Propantheline |
Propantheline |
1件: D00481 D00481 💬 |
CHRM1 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
026 1件: 26 💬 |
30 |
Propantheline bromide |
Propantheline |
1件: D00481 D00481 💬 |
CHRM1 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
026 1件: 26 💬 |
31 |
Raltegravir |
Raltegravir |
1件: D06676 D06676 💬 |
- |
- |
013 4件: 13, 26, 93, 265 💬 |
32 |
Raltegravir and zidovudine |
Raltegravir |
2件: D00413 D00413, D06676 D06676 💬 |
- |
- |
026 1件: 26 💬 |
33 |
Recombinant human interferon beta-1a |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
026 1件: 26 💬 |
34 |
Recombinant interferon alfa |
Interferon alfa |
1件: D03305 D03305 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
026 2件: 26, 28 💬 |
35 |
Sulfate |
Sulfate ion |
- |
- |
- |
002 25件: 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
36 |
Tamibarotene |
Tamibarotene |
1件: D01418 D01418 💬 |
RARA 1件: RARA 💬 |
Acute myeloid leukemia 5件: Acute myeloid leukemia, Estrogen signaling pathway, Pathways in cancer, Th17 cell differentiation, Transcriptional misregulation in cancer |
026 2件: 26, 96 💬 |
37 |
Valproic acid |
Valproic acid |
1件: D00399 D00399 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 10件: 3 , 5 , 26, 34, 65, 89, 90, 222, 256, 331 💬 |
38 |
Valproid acid plus corticosteroids |
- |
- |
- |
- |
026 1件: 26 💬 |
39 |
Vincristine |
Vincristine |
2件: D02197 D02197, D08679 D08679 💬 |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
026 3件: 26, 34, 331 💬 |
40 |
Vincristine sulfate |
Sulfate ion |
2件: D02197 D02197, D08679 D08679 💬 |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
026 2件: 26, 34 💬 |
41 |
Zidovudine |
Zidovudine |
1件: D00413 D00413 💬 |
- |
- |
025 6件: 25, 26, 135, 265, 325, 331 💬 |
42 |
Zidovudine/lamivudine |
Lamivudine |
2件: D00353 D00353, D00413 D00413 💬 |
- |
- |
026 1件: 26 💬 |